Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Phase II, Pembrolizumab combined with chemotherapy as a First line treatment for NSCLC.
Phase: 2Phase II in Spain, 1Phase I